Skip to main content Help with accessibility Skip to main navigation

OMALIZUMAB solution for injection (Xolair®) for chronic rhinosinusitis with nasal polyps

CCG Approval Status:

Date Added: 24 - Sep - 2020
Body System:
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend
the prescribing of OMALIZUMAB solution for injection (Xolair®) for chronic
rhinosinusitis with nasal polyps.